Lung transplantation following controlled hypothermic storage with a portable lung preservation device: first multicenter European experience.

ABSTRACT:

Introduction

Compared with traditional static ice storage, controlled hypothermic storage (CHS) at 4-10°C may attenuate cold-induced lung injury between procurement and implantation. In this study, we describe the first European lung transplant (LTx) experience with a portable CHS device.

Methods

A prospective observational study was conducted of all consecutively performed LTx following CHS (11 November 2022 and 31 January 2024) at two European high-volume centers. The LUNGguard device was used for CHS. The preservation details, total ischemic time, and early postoperative outcomes are described. The data are presented as median (range: minimum-maximum) values.

Results

A total of 36 patients underwent LTx (i.e., 33 bilateral, 2 single LTx, and 1 lobar). The median ag

SUBMITTER: Provoost AL 

PROVIDER: S-EPMC11187339 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature